CRXL - Crucell NV ADS

Your Recent Quotes: 0 | 0

Crucell NV ADS

TRADE NOW Related Information and Financials
Price Glossary Definition
12.07 0.47
4.05%
11/21/08 4:00
Open
11.89
Prev Close
11.60
Volume
97,925
52 Wk. Range
9.42- 20.14
Year-to-Date Performance Glossary Definition
DOWN -27.03%
Latest Dividend
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
-29.74
 
0.00
 
12.60
CRXL
Sect. Av.
S&P 500
Market Cap
758,036,800
Outstanding Shares
65,348,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy CRXL Rating Report
Target Price (1Yr)
High
26.00
Revenue
276,600,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
71.40
8.71
1.12
Net Income
N/A
1.32
0.00
EPS
N/A
0.30
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-29.25
-26.00
-53.36
Earnings Per Share($)

12/2005
 
 
 
-0.46
12/2006
 
 
 
-2.02
12/2007
 
 
 
-1.04

Earnings
EBITDA
-50,185,000
Revenue
297,589,000
Outside Analyst Rating History

11/22/08
1
Buy
11/22/08
0
Hold
11/22/08
0
Sell

Jim Cramer Portfolio
Find out now if CRXL is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
Shares are up 13% as oil prices fell to two-week lows.

4:22PM 06/25/08

Crucell climbs on a new supply deal in its drug development plans.

4:14PM 06/25/08

Abbott Labs climbs on new data from its Spirit III trial for its Xience V stent.

3:58PM 05/13/08

Shares plummet on fears the company's main drug will fail.

4:33PM 04/09/08

Nektar and MannKind tumble on inhaled insulin drug data.

4:28PM 04/09/08

The biotechnology company jumps 13.6% on a commercialization agreement.

4:33PM 01/03/08

Sciele jumps on FDA approval.

3:59PM 01/03/08

Tutogen climbs on a merger deal with Regeneration Technologies.

4:33PM 11/13/07

Panacos falls on the departure of its CFO as well as a downgrade.

3:17PM 09/25/07

Carrizo, Lan Airlines and Albany Molecular upgraded; Crucell and Exide Technologies downgraded.

3:42PM 09/05/07

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading CRXL in his Action Alerts Plus Portfolio?

Premium Services